CaRi-Heart® for comprehensive quantification of coronary inflammation, plaque and risk

Prof. Keith Channon, Chair of Cardiovascular Medicine at the University of Oxford and Chief Medical Officer at Caristo Diagnostics, presented the latest developments on CaRi-Heart® technology and shared findings from the ORFAN study at SCCT Global Meeting 2024, in Budapest. The findings demonstrate the potential for Fat Attenuation Index Score (FAI-Score) to transform risk stratification and management of patients with coronary artery disease.

Watch his presentation here.